Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2009, Article ID 756395, 5 pages
http://dx.doi.org/10.1155/2009/756395
Clinical Study

Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours

1Department of Orthopaedic Surgery, University of Edinburgh, Royal Infirmary of Edinburgh, Little France Crescent, Edinburgh EH16 4SU, UK
2The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham B31 2AP, UK
3Peripheral Nerve Injuries Unit, Royal National Orthopaedic Hospital Trust, Brockley Hill Stanmore, Middlesex HA7 4LP, UK

Received 2 October 2008; Accepted 5 January 2009

Academic Editor: Alessandro Gronchi

Copyright © 2009 D. E. Porter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. F. Doorn, W. M. Molenaar, J. Buter, and H. J. Hoekstra, “Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis,” European Journal of Surgical Oncology, vol. 21, no. 1, pp. 78–82, 1995. View at Publisher · View at Google Scholar
  2. R. E. Ferner and D. H. Gutmann, “International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis,” Cancer Research, vol. 62, no. 5, pp. 1573–1577, 2002. View at Google Scholar
  3. B. S. Ducatman, B. W. Scheithauer, D. G. Piepgras, H. M. Reiman, and D. M. Ilstrup, “Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases,” Cancer, vol. 57, no. 10, pp. 2006–2021, 1986. View at Publisher · View at Google Scholar
  4. D. G. R. Evans, M. E. Baser, J. McGaughran, S. Sharif, E. Howard, and A. Moran, “Malignant peripheral nerve sheath tumours in neurofibromatosis 1,” Journal of Medical Genetics, vol. 39, no. 5, pp. 311–314, 2002. View at Publisher · View at Google Scholar
  5. R. H. Hruban, M. H. Shiu, R. T. Senie, and J. M. Woodruff, “Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases,” Cancer, vol. 66, no. 6, pp. 1253–1265, 1990. View at Publisher · View at Google Scholar
  6. I. M. Ariel, “Tumors of the peripheral nervous system,” Seminars in Surgical Oncology, vol. 4, no. 1, pp. 7–12, 1988. View at Publisher · View at Google Scholar
  7. B. Raney, L. Schnaufer, M. Ziegler, J. Chatten, P. Littman, and P. Jarrett, “Treatment of children with neurogenic sarcoma. Experience at the Children's Hospital of Philadelphia, 1958–1984,” Cancer, vol. 59, no. 1, pp. 1–5, 1987. View at Publisher · View at Google Scholar
  8. M. Bojsen-Moller and O. Myhre-Jensen, “A consecutive series of 30 malignant schwannomas. Survival in relation to clinico-pathological parameters and treatment,” Acta Pathologica Microbiologica et Immunologica Scandinavica A, vol. 92, no. 3, pp. 147–155, 1984. View at Google Scholar
  9. J. E. Wanebo, J. M. Malik, S. R. VandenBerg, H. J. Wanebo, N. Driesen, and J. A. Persing, “Malignant peripheral nerve sheath tumors: a clinicopathologic study of 28 cases,” Cancer, vol. 71, no. 4, pp. 1247–1253, 1993. View at Publisher · View at Google Scholar
  10. D. A. Stumpf, J. F. Alksne, J. F. Annegers et al., “Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference,” Archives of Neurology, vol. 45, no. 5, pp. 575–578, 1988. View at Google Scholar
  11. D. V. Cashen, R. C. Parisien, K. Raskin, F. J. Hornicek, M. C. Gebhardt, and H. J. Mankin, “Survival data for patients with malignant schwannoma,” Clinical Orthopaedics and Related Research, vol. 426, pp. 69–73, 2004. View at Publisher · View at Google Scholar
  12. M. Anghileri, R. Miceli, M. Fiore et al., “Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution,” Cancer, vol. 107, no. 5, pp. 1065–1074, 2006. View at Publisher · View at Google Scholar
  13. R. N. Nambisan, U. Rao, R. Moore, and C. P. Karakousis, “Malignant soft tissue tumors of nerve sheath origin,” Journal of Surgical Oncology, vol. 25, no. 4, pp. 268–272, 1984. View at Publisher · View at Google Scholar
  14. T. R. Loree, J. H. North Jr., B. A. Werness, R. Nangia, A. P. Mullins, and W. L. Hicks Jr., “Malignant peripheral nerve sheath tumors of the head and neck: analysis of prognostic factors,” Otolaryngology—Head and Neck Surgery, vol. 122, no. 5, pp. 667–672, 2000. View at Publisher · View at Google Scholar
  15. T. Zeytoonjian, H. J. Mankin, M. C. Gebhardt, and F. J. Hornicek, “Distal lower extremity sarcomas: frequency of occurrence and patient survival rate,” Foot and Ankle International, vol. 25, no. 5, pp. 325–330, 2004. View at Google Scholar
  16. T. Watanabe, Y. Oda, S. Tamiya, N. Kinukawa, K. Masuda, and M. Tsuneyoshi, “Malignant peripheral nerve sheath tumours: high Ki67 labelling index is the significant prognostic indicator,” Histopathology, vol. 39, no. 2, pp. 187–197, 2001. View at Publisher · View at Google Scholar
  17. B. C. Ghosh, L. Ghosh, A. G. Huvos, and J. G. Fortner, “Malignant schwannoma. A clinicopathologic study,” Cancer, vol. 31, no. 1, pp. 184–190, 1973. View at Publisher · View at Google Scholar
  18. P. P. Sordillo, L. Helson, S. I. Hajdu et al., “Malignant schwannoma—clinical characteristics, survival, and response to therapy,” Cancer, vol. 47, no. 10, pp. 2503–2509, 1981. View at Publisher · View at Google Scholar
  19. R. S. Bridge Jr., J. A. Bridge, J. R. Neff, S. Naumann, P. Althof, and L. A. Bruch, “Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study,” Journal of Clinical Pathology, vol. 57, no. 11, pp. 1172–1178, 2004. View at Publisher · View at Google Scholar
  20. P. Møller, Å. Borg, D. G. Evans et al., “Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy,” International Journal of Cancer, vol. 101, no. 6, pp. 555–559, 2002. View at Publisher · View at Google Scholar
  21. C. Hagel, U. Zils, M. Peiper et al., “Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors,” Journal of Neuro-Oncology, vol. 82, no. 2, pp. 187–192, 2007. View at Publisher · View at Google Scholar
  22. P. D. P. Pharoah, D. F. Easton, D. L. Stockton, S. Gayther, and B. A. J. Ponder, “Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer,” Cancer Research, vol. 59, no. 4, pp. 868–871, 1999. View at Google Scholar
  23. B. R. Seizinger, G. A. Rouleau, L. J. Ozelius et al., “Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene,” Cell, vol. 49, no. 5, pp. 589–594, 1987. View at Publisher · View at Google Scholar
  24. M. J. Fisher, S. Basu, E. Dombi et al., “The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression,” Journal of Neuro-Oncology, vol. 87, no. 2, pp. 165–171, 2008. View at Publisher · View at Google Scholar
  25. W. Brenner, R. E. Friedrich, K. A. Gawad et al., “Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 4, pp. 428–432, 2006. View at Publisher · View at Google Scholar
  26. K. Leroy, V. Dumas, N. Martin-Garcia et al., “Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients,” Archives of Dermatology, vol. 137, no. 7, pp. 908–913, 2001. View at Google Scholar
  27. M. Carli, A. Ferrari, A. Mattke et al., “Pediatric malignant peripheral nerve sheath tumor: the Italian and German Soft Tissue Sarcoma Cooperative Group,” Journal of Clinical Oncology, vol. 23, no. 33, pp. 8422–8430, 2005. View at Publisher · View at Google Scholar
  28. NHS National Institute for Health and Clinical Excellence, “Improving Outcomes for People with Sarcoma. The Manual,” March 2006, http://www.nice.org.uk/nicemedia/pdf/SarcomaFullGuidance.pdf.